Danaher (DHR) | Stock Overview & Key Data

Danaher Corporation | Healthcare

US$210.26

-1.18%

| Compare Stocks:

Danaher vs Thermo Fisher Danaher vs Idexx Laboratories Danaher vs Agilent Technologies Danaher vs Iqvia Holdings Danaher vs Mettler-Toledo Danaher vs S&P 500 | Market

Danaher Performance Comparison

Loading chart data...

Danaher

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: US$208.65 High: US$212.40

on May 15, 2025

52 Week Range

Low: US$196.80 High: US$281.70

on February 12, 2025

on August 1, 2024

All-Time High: US$213.78 on March 17, 2025

Key Statistics

Market Cap i $136.7B

EPS i 5.16

P/E Ratio (TTM) i 37.01

Forward P/E i 22.79

P/B Ratio i 2.69

PEG Ratio i 22.79

Div. Yield i 0.58%

ROE i 7.22%

Beta i 0.834

Debt to Equity i 34.56

Financial Highlights

Profitability

Gross Margin i 61.16%

Operating Margin i 22.49%

Profit Margin i 15.81%

Returns and Earnings

Return on Assets (TTM) i 3.93%

Return on Equity (TTM) i 7.22%

EBITDA i $7.2B

Net Income (TTM) i $3.8B

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Dividend Information

Expected Yearly Dividend i US$1.28

Estimated Dividend Yield i 0.66%

5 Year Average Dividend Yield i 0.38%

Last 12-Month Dividend Yield i 0.58%

Last 12-Month Dividend i US$1.13

% of Earnings Paid as Dividends i 21.90%

Dividend Date i July 25, 2025

Ex-Dividend Date i June 27, 2025

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Danaher DHR	136.66B Large-cap	3.01%	1.10%	-8.01%	-22.88%	-8.52%	-0.24%	-0.24%	-0.24%
Thermo Fisher TMO	152.18B Large-cap	-1.42%	-8.18%	-22.59%	-21.08%	-22.51%	-32.01%	-27.10%	18.95%
Idexx Laboratories IDXX	40.97B Large-cap	4.45%	26.67%	13.97%	21.59%	25.18%	-5.83%	37.48%	73.64%
Agilent Technologies A	32.05B Large-cap	3.30%	8.89%	-16.95%	-11.63%	-15.84%	-27.14%	-10.20%	32.23%
Iqvia Holdings IQV	24.53B Large-cap	-8.35%	-5.81%	-27.26%	-27.09%	-28.00%	-39.25%	-30.41%	-1.71%
Mettler-Toledo MTD	24.41B Large-cap	4.04%	9.51%	-9.98%	-2.84%	-6.12%	-24.84%	-7.60%	52.94%

Ownership & Short Interest

Insider Ownership i 11.04%

Institutional Ownership i 79.18%

Shares Short i 8M

Short Ratio i 1.62

Short % of Shares Outstanding i 1.22%

Average 10-Day Volume i 4M

Average 90-Day Volume i 5M

Danaher Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Danaher would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is DHR's 52-week high and low?

In the last 52 weeks, Danaher reached a high of US$281.70 (on August 1, 2024) and a low of US$196.80 (on February 12, 2025).

What is the market cap and P/E ratio for DHR?

Curious about Danaher's size and valuation? Its market capitalization stands at 136.66B. When it comes to valuation, the P/E ratio (trailing twelve months) is 37.01, and the forward P/E (looking ahead) is 22.79.

Does DHR pay dividends? If so, what's the yield?

Yes, Danaher is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.58%, and the company is expected to pay out US$1.28 per share over the coming year.

Who are Danaher's main competitors or similar companies to consider before investing?

When looking at Danaher, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Thermo Fisher TMO	152.18B	Healthcare	Diagnostics & Research	-32.01%	-27.10%
Idexx Laboratories IDXX	40.97B	Healthcare	Diagnostics & Research	-5.83%	37.48%
Agilent Technologies A	32.05B	Healthcare	Diagnostics & Research	-27.14%	-10.20%
Iqvia Holdings IQV	24.53B	Healthcare	Diagnostics & Research	-39.25%	-30.41%
Mettler-Toledo MTD	24.41B	Healthcare	Diagnostics & Research	-24.84%	-7.60%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Danaher Corporation? (e.g., ROE, Debt/Equity)

To get a sense of Danaher's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 7.22%, the Debt to Equity ratio from the most recent quarter is 34.56, and its Gross Profit Margin stands at 61.16%.

What is the recent revenue and earnings growth for DHR?

Looking at Danaher's growth, its revenue over the trailing twelve months (TTM) was $24B. Compared to the same quarter last year (YoY), quarterly revenue grew by -0.90%, and quarterly earnings saw a YoY growth of -12.30%.

How much of DHR stock is held by insiders and institutions?

Wondering who owns Danaher stock? Company insiders (like executives and directors) hold about 11.04% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 79.18%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.